Ketoconazole renders poor CYP3A phenotype status with midazolam as probe drug.
Tham LS, Lee HS, Wang L, Yong WP, Fan L, Ong AB, Sukri N, Soo R, Lee SC, Goh BC.
Tham LS, et al. Among authors: lee hs, lee sc.
Ther Drug Monit. 2006 Apr;28(2):255-61. doi: 10.1097/01.ftd.0000194497.55269.d9.
Ther Drug Monit. 2006.
PMID: 16628140
Clinical Trial.